Drug Development Research

Papers
(The H4-Index of Drug Development Research is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Novel matrinic acid derivatives bearing 2‐anilinothiazole structure for non‐small cell lung cancer treatment with improved Hsp90 targeting effect93
Safety study of topical naltrexone therapy for diabetic skin wounds is confirmed in Göttingen mini‐pigs79
Anti‐inflammatory effect and mechanism of catalpol in various inflammatory diseases66
Terbutaline attenuates LPS ‐induced injury of pulmonary microvascular endothelial cells by cAMP /Epac signaling59
CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR ‐153‐3p/ ATF2 axis and57
A growth‐based assay using fluorescent protein emission to screen for S‐adenosylmethionine synthetase inhibitors49
Research Progress of Endoplasmic Reticulum Targeting Metal Complexes in Cancer Therapy47
Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)‐sensitive and ‐resistant strains47
Bioinformatics Exploration of the Therapeutic Potential of Lotus Seed Compounds in Multiple Sclerosis: A Network Analysis of c‐Jun Pathway43
Trifolirhizin targets PTK6 to induce autophagy and exerts antitumor effects in nasopharyngeal carcinoma39
Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment33
Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone‐based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease29
Advancements in Organoid‐Based Drug Discovery: Revolutionizing Precision Medicine and Pharmacology28
Therapeutic potential and research progress of diosgenin for lipid metabolism diseases27
Recent Development in Celiac Disease: Pathophysiology, Animal Models and Treatments27
Issue Information24
Issue Information24
24
New pyrrole derivatives as DNA gyrase and 14α‐demethylase inhibitors: Design, synthesis, antimicrobial evaluation, and molecular docking23
Ricolinostat suppresses proliferation, promotes apoptosis, and enhances the antiproliferative activity of topoisomerase inhibitors in cervical cancer cells23
PX‐12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro23
Issue Information22
T‐17, a novel cyclin‐dependent kinases/histone deacetylases dual inhibitor, induces cancer cells death through cell cycle arrest and apoptosis22
0.042797088623047